Agilent (NYSE: A) director Wilson Dow reports fully vested stock grant

Rhea-AI Filing Summary

Agilent Technologies director Wilson Dow reported receiving an award of 2,158 shares of common stock on March 19, 2026 at a reference price of $111.75 per share. This was a fully vested stock grant for non-employee directors, classified as a compensation-related acquisition rather than an open-market purchase.

After the award, Dow directly holds 20,368.606 shares of Agilent common stock. A footnote also states that 144.124 shares were acquired through the company’s dividend reinvestment plan and have been deferred by the reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON DOW R

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		A		2,158	A	$111.75(1)	20,368.606(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

2. 144.124 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.

Remarks:

See Exhibit 24 - Power of Attorney

	/s/ Shirley Qin, attorney-in-fact for Mr. Wilson	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Agilent (A) director Wilson Dow report in this Form 4?

Wilson Dow reported receiving an award of Agilent common stock, not buying shares in the open market. The Form 4 shows a fully vested grant to a non-employee director, increasing his direct holdings in the company.

How many Agilent (A) shares were granted to Wilson Dow and at what price?

Wilson Dow received 2,158 shares of Agilent common stock, with a reference price of $111.75 per share. This was recorded as a grant or award, reflecting compensation for board service rather than a discretionary stock purchase.

What are Wilson Dow’s Agilent (A) holdings after this stock award?

Following the reported grant, Wilson Dow directly holds 20,368.606 shares of Agilent common stock. This total reflects his updated position after the award and provides context for the relative size of the compensation-related transaction.

Was the Agilent (A) Form 4 transaction an open-market buy or a grant?

The transaction was a grant or award acquisition, not an open-market purchase. The filing classifies it under code A, indicating shares granted as compensation to a non-employee director and fully vested upon grant, rather than bought on the market.

What does the dividend reinvestment footnote in the Agilent (A) Form 4 mean?

A footnote states that 144.124 shares were acquired through Agilent’s dividend reinvestment plan and that Dow elected to defer these shares. This indicates additional share accumulation via reinvested dividends, separate from the main stock grant reported.

Does the Agilent (A) Form 4 show any derivative or option exercises?

The Form 4 does not report any derivative or option exercises for Wilson Dow. It only shows a non-derivative stock grant and notes dividend reinvestment plan shares, with no remaining derivative positions listed in the derivative summary section.